“Low dose” colestipol in children, adolescents and young adults with familial hypercholesterolemia

This publication has 20 references indexed in Scilit:

• Cholestyramine in type IIa hyperlipoproteinemia
  Atherosclerosis, 1981
• LONG-TERM FOLLOW-UP OF CHILDREN WITH FAMILIAL HYPERCHOLESTEROLÆMIA TREATED WITH CHOLESTYRAMINE
  The Lancet, 1980
• Effects of nicotinic acid therapy on high-density ldpoprotein metabolism in type II and type IV hyperlipoproteinaemia
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
• Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism
  Journal of Clinical Investigation, 1979
• Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
  Circulation, 1979
• Quantitation of the major apoproteins of human high density lipoproteins by solid phase radioimmunoassay
  FEBS Letters, 1978
• DOSE-EFFECT RELATION OF CHOLESTYRAMINE IN CHILDREN AND YOUNG ADULTS WITH FAMILIAL HYPERCHOLESTEROLÆMIA
  The Lancet, 1977
• Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia
  Circulation, 1974
• Use of cholestyramine in treatment of children with familial hypercholesterolaemia
  Archives of Disease in Childhood, 1973
• TREATMENT OF FAMILIAL HYPERCHOLESTEROLÆMIA IN CHILDREN
  The Lancet, 1970